Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model

Roxanne Wouters, Sara Westrøm, Yani Berckmans, Matteo Riva, Jolien Ceusters, Tina B. Bønsdorff, Ignace Vergote, An Coosemans

Open source

DOI
10.3389/fmed.2022.995325
Published
2022-10-10
Container
Frontiers in Medicine
Publisher
Frontiers Media SA
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2022.995325,
  title = {Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model},
  author = {Roxanne Wouters and Sara Westrøm and Yani Berckmans and Matteo Riva and Jolien Ceusters and Tina B. Bønsdorff and Ignace Vergote and An Coosemans},
  year = {2022},
  journal = {Frontiers in Medicine},
  doi = {10.3389/fmed.2022.995325},
  url = {https://doi.org/10.3389/fmed.2022.995325}
}

RIS

TY  - JOUR
TI  - Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model
AU  - Roxanne Wouters
AU  - Sara Westrøm
AU  - Yani Berckmans
AU  - Matteo Riva
AU  - Jolien Ceusters
AU  - Tina B. Bønsdorff
AU  - Ignace Vergote
AU  - An Coosemans
PY  - 2022
JO  - Frontiers in Medicine
DO  - 10.3389/fmed.2022.995325
UR  - https://doi.org/10.3389/fmed.2022.995325
ER  - 

APA

Wouters, R., Westrøm, S., Berckmans, Y., Riva, M., Ceusters, J., Bønsdorff, T. B., Vergote, I., & Coosemans, A. (2022). Intraperitoneal alpha therapy with 224Ra-labeled microparticles combined with chemotherapy in an ovarian cancer mouse model. Frontiers in Medicine. https://doi.org/10.3389/fmed.2022.995325

Source records